Correlation Between V Tac and Maxigen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both V Tac and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining V Tac and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between V Tac Technology Co and Maxigen Biotech, you can compare the effects of market volatilities on V Tac and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in V Tac with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of V Tac and Maxigen Biotech.

Diversification Opportunities for V Tac and Maxigen Biotech

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between 6229 and Maxigen is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding V Tac Technology Co and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and V Tac is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on V Tac Technology Co are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of V Tac i.e., V Tac and Maxigen Biotech go up and down completely randomly.

Pair Corralation between V Tac and Maxigen Biotech

Assuming the 90 days trading horizon V Tac Technology Co is expected to under-perform the Maxigen Biotech. In addition to that, V Tac is 1.39 times more volatile than Maxigen Biotech. It trades about -0.06 of its total potential returns per unit of risk. Maxigen Biotech is currently generating about 0.01 per unit of volatility. If you would invest  4,490  in Maxigen Biotech on September 3, 2024 and sell it today you would lose (30.00) from holding Maxigen Biotech or give up 0.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

V Tac Technology Co  vs.  Maxigen Biotech

 Performance 
       Timeline  
V Tac Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days V Tac Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Maxigen Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maxigen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Maxigen Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

V Tac and Maxigen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with V Tac and Maxigen Biotech

The main advantage of trading using opposite V Tac and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if V Tac position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.
The idea behind V Tac Technology Co and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum